Aspira Women's Health raises $3.06M in private placement at $0.45/unit, issues 6.55M shares

Aspira Women's Health Inc.

Gross proceeds $2.95M from sale of 6.55M shares and 4.91M warrants at $0.45/unit; plus $112.5K from exercise of 450K warrants.
Each unit: 1 share + 0.75 warrant; warrants exercisable at $0.75/share for 5 years.
Net proceeds used for working capital, commercial activities, and general corporate purposes.
Board members participated as investors alongside existing and new accredited investors.
Total new shares issued ~7.0M; warrant overhang 4.91M shares at $0.75 exercise price.

Key facts

Extracted from this filing and checked against the source text.

Equity Issuances SEC 8-K Item 3.02/3.03 confidence 0.9

Aspira Women's Health Inc. issued 6,550,000 shares of common stock to accredited and institutional investors for $0.45 per share.

Security: common stock
Shares: 6,550,000 shares
Purchaser: accredited and institutional investors
Consideration: $0.45 per share

Exact text from the filing

stock, par value $0.001 (the “Common Stock”) and (ii) warrants (the “Common Warrants”) to purchase up to 4,912,500 shares of the Company’s Common Stock, at a purchase price of $0.45 per share of Common Stock and accompanying warrants. The Common Warrants are exercisable immediately upon issuance at an exercise price of $0.75 per share and have a term of

View on SEC.gov

Equity Issuances SEC 8-K Item 3.02/3.03 confidence 0.9

Aspira Women's Health Inc. issued up to 4,912,500 shares of warrant to accredited and institutional investors for $0.45 per share of Common Stock and accompanying warrants.

Security: warrant
Shares: up to 4,912,500 shares
Purchaser: accredited and institutional investors
Consideration: $0.45 per share of Common Stock and accompanying warrants

Exact text from the filing

stock, par value $0.001 (the “Common Stock”) and (ii) warrants (the “Common Warrants”) to purchase up to 4,912,500 shares of the Company’s Common Stock, at a purchase price of $0.45 per share of Common Stock and accompanying warrants. The Common Warrants are exercisable immediately upon issuance at an exercise price of $0.75 per share and have a term of

View on SEC.gov

Browse all equity issuances →

Aspira Women's Health Inc. filing history →

Source: SEC EDGAR

accession 0001493152-25-013987

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.